The recently launched co-axial VIP EVO Valve from Italy-based OMAL provides the lowest cost of ownership with a life expectancy 10 times that of a ball valve/actuator combination and reduced maintenance costs. It integrates the valve and actuator into a single compact device, minimises pressure losses and has multi-functional security holes that prevent air supply system damage.

The VIP EVO Valve saves at least 70% of compressed air when compared to an equivalent ball valve with SR pneumatic actuator. Compatible with LPG and LNG gas, oxygen, nitrogen, petroleum, air and water, among others, its easily accessible limit switches are adjustable on both sides. The EVO Valve allows for different materials for different applications and has a switching time of less than 0.2 seconds for valves up to one inch.

Available in double acting and spring return VIP valves in sizes from 3/8 to 2 inches, it is ideal for use with fire-fighting applications, aviation refuelling systems, gas filling units and PSA generators among other applications.

Fewer mechanical parts translate to reduced friction and therefore less wear, and this is what facilitates the valve’s considerable longevity. Reduced downtime and lower production losses combined with energy savings and minimised inventory, means the VIP EVO Valve provides ROI in as little as three months.

Warrantied for up to 300 000 cycles (model dependent), VIP EVO can be used in horizontal, vertical or angled mounting. It is available with EPDM, NBR and FKM seals, is ATEX and PED certified and certified up to SIL 3. It features an integrated slot for the valve position sensor, facilitating easily sensor mounting in both sides of the valve, minimising space. Risk of injury to personnel is reduced by the omission of any external moving parts on the valve.

 

Wade Profitt
Tectra Automation
Tel. +27 11 971 9400
Wade.Profitt@boschrexroth.co.za

Share this article
  •  
  •  
  •  
  •  
  •  
  •  
  •  

In terms of the Government Gazette Vol:657 Dated 26 March 2020 No 43164 - Information regarding COVID19 can be found at HERE